We subsequently confirmed that maintenance of regulatory T cell (Treg cell) numbers in asthma patients with CEP may inhibit EGPA development via the action of cytokines, such as IL-10 and IL-2, produced by CD4+CD25+ and CD4+CD25− T cells, respectively [7]. The gene discussed is CD4; the disease is eosinophilic granulomatosis with polyangiitis.